We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Clinical Laboratory Diagnostics Tool Targeted Towards Addiction

By LabMedica International staff writers
Posted on 30 Jun 2010
A privately held clinical urine drug-testing laboratory offers a reporting service that provides clinicians with accurate testing results and analytical feedback to augment the assessment and monitoring of an individual's drug use upon admission and throughout the course of addiction treatment.

The new Comprehensive Analysis of Reported Drugs (CARD) reporting service was developed to create a highly personalized clinical report by correlating an individual's prescribed medication use and self-reported drug misuse with its state-of-the-art diagnostic testing.

Dominion Diagnostics (North Kingstown, RI, USA) performs all the necessary testing at its laboratory and turns around testing results to clients through a number of different formats. The initial results are deliverable 24 hours from receipt of the specimen in the laboratory, with confirmatory results by alternate method available within a few days. Dominion works with a variety of medical specialties, but the new CARD report is in fact targeted towards addiction treatment and behavioral health.

CARD utilizes laboratory results from validated quantitative urine drug testing profiles for commonly abused illicit and prescription drugs and/or their metabolites, as well as biological markers and commercial adulterant screening (i.e., creatinine, specific gravity, pH, and oxidants) to ensure specimen validity.

The results provide data to support and measure a treatment program's ability to reduce morbidity in substance abuse, improve retention in treatment, and promote the use of evidence-based practice for individuals suffering from addiction and mental health disorders, in line with ongoing initiatives supported by the Substance Abuse and Mental Health Services Agency (SAMHSA; Rockville, MD, USA).

Dominion Diagnostics is a premier provider of comprehensive clinical quantitative urine drug testing, medication monitoring, and support services nationwide.

Related Links:
Dominion Diagnostics
Substance Abuse and Mental Health Services Agency



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
30 Jun 2010  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
30 Jun 2010  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
30 Jun 2010  |   Clinical Chem.